Royal jelly supplement tested for boosting fertility in women

NCT ID NCT07246733

Recruiting now Disease control Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a dietary supplement made from royal jelly (MRJPs) can improve ovarian function and the thickness of the uterine lining in women with diminished ovarian reserve or thin endometrium. Sixty-six women aged 20 to 45 will take either the supplement or a placebo for one menstrual cycle. Researchers will measure hormone levels and use ultrasound to check for changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MRJPs (royal jelly tablets)
What this could lead to: If it works, this could point toward a dietary supplement to support fertility in women with low ovarian reserve or thin uterine lining.
What could go wrong: This is a small early-phase trial with only 66 participants, so results may not apply widely. The supplement is not a proven treatment and may have no effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIMINISHED OVARIAN RESERVE (DOR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIMINISHED OVARIAN RESERVE (DOR) THIN ENDOMETRIUM

Contacts and locations

Locations

The Fourth Affiliated Hospital of Zhejiang University School of Medicine
RECRUITING

Yiwu, Zhejiang, 322000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.